Carregant...
Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy
Since the early clinical studies of cancer immunotherapy, the question arose as to whether it was possible to combine it with standard cancer treatments, mostly chemotherapy. The answer, now, is past history. The combined use of immunotherapy and chemotherapy is not only possible but, in certain cas...
Guardat en:
| Publicat a: | Mol Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528384/ https://ncbi.nlm.nih.gov/pubmed/22177803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2011.11.005 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|